Lmr Partners LLP Alkermes Plc. Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $538,835 - $721,603	-28,692 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $522,481 - $665,654	28,692 New	28,692 $536,000
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $204,911 - $333,255	-15,690 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $271,280 - $341,100	15,690 New	15,690 $320,000

363

181M

175K

96.6K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.72B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.